Explore

Trendline Trendline
FDA Authorizes Caristo Diagnostics' CaRi-Heart Technology for Coronary Inflammation Assessment

FDA Authorizes Caristo Diagnostics' CaRi-Heart Technology for Coronary Inflammation Assessment

FDA Authorizes Caristo Diagnostics' CaRi-Heart Technology for Coronary Inflammation Assessment
Trendline Trendline
Longevity Clinics Embrace Preventative Medicine to Extend Healthspan

Longevity Clinics Embrace Preventative Medicine to Extend Healthspan

Longevity Clinics Embrace Preventative Medicine to Extend Healthspan
Trendline Trendline
Longevity Clinics Emerge as a $250 Billion Market Focused on Health Span

Longevity Clinics Emerge as a $250 Billion Market Focused on Health Span

Longevity Clinics Emerge as a $250 Billion Market Focused on Health Span
Rapid Read Rapid Read
Pharmacogenomics Advances in Primary Care: Enhancing Drug Prescribing Accuracy

Pharmacogenomics Advances in Primary Care: Enhancing Drug Prescribing Accuracy

Pharmacogenomics (PGx) is increasingly being integrated into primary care to improve the accuracy of drug prescriptions. Traditionally, medications have been prescribed based on trial-and-error methods, which can lead to adverse drug reactions (ADRs) due to the variability in individual patient responses. PGx testing utilizes genetic markers to tailor drug prescriptions, potentially reducing ADRs by 30%, as evidenced by recent studies. This approach allows clinicians to make more informed decisions by considering a patient's genetic profile, thereby enhancing the efficacy and safety of prescribed medications. The integration of PGx into primary care is supported by tools that provide genotype and predicted phenotypic responses, offering personalized medication guidance.
Rapid Read Rapid Read
Study Reveals Low-Carb Diets May Increase Cholesterol in Genetically Predisposed Individuals

Study Reveals Low-Carb Diets May Increase Cholesterol in Genetically Predisposed Individuals

Recent research presented at the American Society for Nutrition's annual meeting indicates that low-carbohydrate diets can lead to increased cholesterol levels in individuals with certain genetic predispositions. The study analyzed data from the DIETFITS trial, which involved over 600 adults following either a low-carb or low-fat diet for a year. Researchers found that participants with a genetic tendency for elevated LDL cholesterol experienced significant increases in cholesterol levels when on a low-carb diet. This correlation was not observed in those following a low-fat diet. The study highlights the importance of genetic factors in cholesterol management and suggests that dietary choices may need to be tailored based on individual genetic profiles.
Rapid Read Rapid Read
Labcorp Introduces Genetic Health Panel to Enhance Consumer Access to Genetic Testing

Labcorp Introduces Genetic Health Panel to Enhance Consumer Access to Genetic Testing

Labcorp has launched the Marker by Labcorp™ Genetic Health Panel, a new service designed to help consumers understand inherited risks for over 100 health conditions. Available through Labcorp OnDemand, the panel analyzes 163 genes related to hereditary cancer, cardiovascular, and metabolic conditions. It includes access to genetic counselors to assist consumers in interpreting results and planning next steps. This initiative aims to bridge the gap in consumer access to genetic testing, providing a comprehensive healthcare experience by combining genetic testing, specimen collection, and counseling.
Rapid Read Rapid Read
Updated Guidelines for Sepsis Management Emphasize Early Intervention and Tailored Treatment

Updated Guidelines for Sepsis Management Emphasize Early Intervention and Tailored Treatment

The Surviving Sepsis Campaign has released updated international guidelines for the management of sepsis and septic shock, focusing on early identification and intervention. The guidelines recommend immediate treatment and resuscitation for sepsis and septic shock, emphasizing the importance of administering antimicrobials within one hour of recognition. The guidelines also suggest using dynamic measures to guide fluid resuscitation and recommend norepinephrine as the first-line vasopressor for septic shock. Additionally, the guidelines highlight the use of Veno-venous ECMO for severe ARDS when conventional ventilation fails. These recommendations aim to improve patient outcomes by providing clinicians with evidence-based strategies for managing sepsis in hospital settings.
Trendline Trendline
Epigenomics Market Poised for Growth with Focus on Precision Medicine

Epigenomics Market Poised for Growth with Focus on Precision Medicine

Epigenomics Market Poised for Growth with Focus on Precision Medicine
Trendline Trendline
Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends

Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends

Neko Health's Full-Body Scan Gains Popularity Amid Wellness Trends
Trendline Trendline
Metabolic Health Optimization Linked to Longevity and Disease Prevention

Metabolic Health Optimization Linked to Longevity and Disease Prevention

Metabolic Health Optimization Linked to Longevity and Disease Prevention
Rapid Read Rapid Read
New Cholesterol Guidelines Expand Statin Eligibility to Millions More Americans

New Cholesterol Guidelines Expand Statin Eligibility to Millions More Americans

A recent study has revealed that an estimated 21.5 million additional adults in the United States may now be eligible for statin therapy under updated cholesterol treatment guidelines. These guidelines, issued by the American Heart Association, the American College of Cardiology, and nine other medical societies, aim to prevent cardiovascular diseases by expanding the age range for risk assessment and lowering the thresholds for categorizing cardiovascular risk. The new guidelines apply to adults aged 30 to 79, compared to the previous focus on those aged 40 to 75. The changes could increase the total number of Americans eligible for statins to approximately 87.5 million, or more than half of adults aged 30 to 79. The guidelines also emphasize long-term cardiovascular risk and give greater weight to certain medical conditions, such as advanced chronic kidney disease and HIV.
Rapid Read Rapid Read
Survey Reveals High Demand for Alzheimer's Blood Tests Among Midlife Women, Yet Few Doctors Discuss It

Survey Reveals High Demand for Alzheimer's Blood Tests Among Midlife Women, Yet Few Doctors Discuss It

A recent survey conducted by Harris Poll for HealthyWomen found that 90% of women aged 45 to 64 are open to taking a blood test for early Alzheimer's detection, but only 9% have had this conversation with their healthcare providers. The survey highlights a significant gap between patient interest and medical practice, as many women report cognitive changes and a family history of Alzheimer's. Despite the availability of FDA-cleared blood tests for Alzheimer's, awareness remains low, with only 13% of women familiar with these tests. The survey underscores the need for more proactive discussions about cognitive health in medical settings.